A major medical achievement has been added to Oman’s accomplishment in the field of Cardiology Diseases. A medical team in the Royal Hospital ( RH) has successfully performed innovative therapeutic Technology by implanted a device in the left atrial appendage (LAA) of the heart of a patient suffered an Atrial Fibrillation (AF) and Coronary Artery Stegnosis.

The catheter was performed in RH presided by Dr. Mohammed Al Mokhaini, Heart Diseases Senior Consultant and Head of the National Heart Center,  Dr. Najeeb Al Rawahi, Electrical heart diseases Senior Consultant , with the collaboration of anesthetics , nursing staff and heart technicians.

It is worth to note that this therapeutic technology involves several advantages such as avoiding open heart surgeries, patient can stop taking blood thinning medicines after six weeks of the catheter, has less side effects compared to traditional surgeries, patient can lead a normal life after two days of the catheter.